Skip to main content
JHS Svendgaard Laboratories Ltd. logo

JHS Svendgaard Laboratories Ltd. — Investor Relations & Filings

Ticker · JHS ISIN · INE544H01014 LEI · 335800NYNAOOMRTTWW75 BSE.NS Manufacturing
Open in API
Filings indexed 678 across all filing types
Latest filing 2023-08-15 M&A Activity
Country IN India
Listing BSE.NS JHS

About JHS Svendgaard Laboratories Ltd.

https://www.svendgaard.com/

JHS Svendgaard Laboratories Ltd. is a specialized manufacturer of oral care products, operating primarily through contract manufacturing and private labeling arrangements. The company provides end-to-end solutions for oral hygiene, including the production of toothbrushes, toothpastes, mouthwashes, and specialized dental care items. It maintains large-scale manufacturing facilities equipped to handle high-volume production for global and domestic FMCG brands. In addition to its business-to-business operations, the company manages its own consumer brand, Aquawhite, which focuses on innovative oral care solutions for various age groups, including a significant range of licensed character-based products for children. The organization emphasizes quality control and technical expertise in oral health product development, catering to diverse market segments through a robust supply chain and distribution network.

Recent filings

Filing Released Lang Actions
Updates
M&A Activity Classification · 95% confidence The document is a formal announcement addressed to stock exchanges (BSE and NSE) regarding a Board of Directors meeting held on August 14, 2023. The key content is about the Board's in-principle agreement to a proposed amalgamation (merger) between JHS Svendgaard Laboratories Limited and Vedic Cosmeceuticals Private Limited (VCPL). The document discusses the business rationale, synergy benefits, and next steps for the scheme of arrangement for amalgamation. It is a regulatory disclosure under SEBI Listing Regulations, specifically Regulation 30, which mandates disclosure of material events including mergers and acquisitions. The document does not contain detailed financial statements or full merger documentation but announces the Board's decision and intention to proceed with the amalgamation. This fits the category of M&A Activity (TAR) as it is an announcement related to a merger proposal and takeover bid, but not a full merger filing (MA). The document length (5168 characters) and content confirm it is not a full annual or interim report, nor a proxy or voting result. Therefore, the classification is M&A Activity (TAR) with high confidence.
2023-08-15 English
Financial Result Updates
Regulatory Filings
2023-08-14 English
Outcome of Board Meeting
Regulatory Filings
2023-08-14 English
Board Meeting — JHS SVENDGAARD LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 14-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the C…
Regulatory Filings
2023-08-07 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve the unaudited financial results for the quarter ended June 30, 2023, along with the limited review report. It is a formal announcement to stock exchanges about the upcoming board meeting and related compliance with insider trading regulations. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is a short notice (1608 characters) indicating a future event and report approval. Therefore, it is not an Interim/Quarterly Report (IR) or Earnings Release (ER), but rather a Regulatory Filing (RNS) announcing the board meeting and upcoming financial results approval.
2023-08-07 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming no requests for dematerialization or rematerialization of securities for the quarter ending June 30, 2023. It is addressed to stock exchanges and signed by the company secretary and the registrar & share transfer agent. The document is short (2271 characters) and serves as a compliance certificate rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or audit information. It is primarily an officer certification and confirmation letter related to regulatory compliance. According to the rules, such documents should be classified as Regulatory Filings (RNS).
2023-07-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.